Childrens Allergy
NDC 51316-260, Fexofenadine HCl, suspension, from CVS PHARMACY, INC.
- Product NDC
- 51316-260
- Status
- Listed
- Labeler
- CVS PHARMACY, INC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA203330
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51316-260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE30 mg/5mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51316-260-04 | 51316026004 | 1 BOTTLE, PLASTIC in 1 BOX (51316-260-04) / 118 mL in 1 BOTTLE, PLASTIC |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51316-260 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51316-260 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51316-260. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.